• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小窝蛋白-1增强组织因子途径抑制物在细胞表面的暴露及功能。

Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface.

作者信息

Lupu Cristina, Hu Xiaohong, Lupu Florea

机构信息

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA.

出版信息

J Biol Chem. 2005 Jun 10;280(23):22308-17. doi: 10.1074/jbc.M503333200. Epub 2005 Apr 6.

DOI:10.1074/jbc.M503333200
PMID:15817451
Abstract

Tissue factor pathway inhibitor (TFPI) blocks tissue factor-factor VIIa (TF-FVIIa) activation of factors X and IX through the formation of the TF-FVIIa-FXa-TFPI complex. Most TFPI in vivo associates with caveolae in endothelial cells (EC). The mechanism of this association and the anticoagulant role of caveolar TFPI are not yet known. Here we show that expression of caveolin-1 (Cav-1) in 293 cells keeps TFPI exposed on the plasmalemma surface, decreases the membrane lateral mobility of TFPI, and increases the TFPI-dependent inhibition of TF-FVIIa. Caveolae-associated TFPI supports the co-localization of the quaternary complex with caveolae. To investigate the significance of these observations for EC we used RNA interference to deplete the cells of Cav-1. Functional assays and fluorescence microscopy revealed that the inhibitory properties of TFPI were diminished in EC lacking Cav-1, apparently through deficient assembly of the quaternary complex. These findings demonstrate that caveolae regulate the inhibition by cell-bound TFPI of the active protease production by the extrinsic pathway of coagulation.

摘要

组织因子途径抑制物(TFPI)通过形成组织因子 - 因子VIIa - 因子Xa - TFPI复合物来阻断组织因子 - 因子VIIa(TF - FVIIa)对因子X和因子IX的激活。体内的大多数TFPI与内皮细胞(EC)中的小窝相关联。这种关联的机制以及小窝TFPI的抗凝作用尚不清楚。在这里,我们表明293细胞中小窝蛋白 - 1(Cav - 1)的表达使TFPI暴露于质膜表面,降低了TFPI的膜侧向流动性,并增强了TFPI对TF - FVIIa的依赖性抑制作用。与小窝相关的TFPI支持四元复合物与小窝的共定位。为了研究这些观察结果对内皮细胞的意义,我们使用RNA干扰来耗尽细胞中的Cav - 1。功能测定和荧光显微镜检查显示,在缺乏Cav - 1的内皮细胞中,TFPI的抑制特性减弱,显然是由于四元复合物组装不足。这些发现表明,小窝调节细胞结合的TFPI对凝血外源性途径产生活性蛋白酶的抑制作用。

相似文献

1
Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface.小窝蛋白-1增强组织因子途径抑制物在细胞表面的暴露及功能。
J Biol Chem. 2005 Jun 10;280(23):22308-17. doi: 10.1074/jbc.M503333200. Epub 2005 Apr 6.
2
Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.配体诱导的蛋白酶受体易位至小窝:一种调节组织因子依赖性凝血途径细胞表面蛋白水解的机制。
J Cell Biol. 1996 Apr;133(2):293-304. doi: 10.1083/jcb.133.2.293.
3
Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium.内皮细胞中的组织因子途径抑制剂与糖脂微区/小窝共定位。内皮细胞抗凝特性的调节机制。
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2964-74. doi: 10.1161/01.atv.17.11.2964.
4
Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.小窝优化细胞表面相关组织因子途径抑制剂对组织因子-Factor VIIa 的抑制活性。
Biochem J. 2012 Apr 1;443(1):259-66. doi: 10.1042/BJ20111994.
5
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.组织因子途径抑制物α和β在乳腺癌细胞表面表达并抑制 TF-FVIIa 活性。
J Hematol Oncol. 2013 Jan 15;6:5. doi: 10.1186/1756-8722-6-5.
6
Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.探究四聚体复合物组织因子-因子VIIa-因子Xa-组织因子途径抑制剂中因子Xa与组织因子之间的界面。
Eur J Biochem. 2003 Jun;270(12):2576-82. doi: 10.1046/j.1432-1033.2003.03625.x.
7
Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen.新型蛋白 ADTRP 在正常条件下以及雄激素应答时调节人内皮细胞中 TFPI 的表达和功能。
Blood. 2011 Oct 20;118(16):4463-71. doi: 10.1182/blood-2011-05-355370. Epub 2011 Aug 25.
8
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).小分子肽可阻断组织因子途径抑制物(TFPI)对因子 Xa 和组织因子-因子 VIIa 的抑制作用。
J Biol Chem. 2014 Jan 17;289(3):1732-41. doi: 10.1074/jbc.M113.533836. Epub 2013 Nov 25.
9
Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.组织因子途径抑制剂定位于脂筏并非抑制因子VIIa/组织因子活性所必需。
Thromb Haemost. 2003 Jan;89(1):65-73.
10
Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.肝素对培养的人内皮细胞中组织因子途径抑制物产生和释放的细胞效应。
Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2251-62. doi: 10.1161/01.atv.19.9.2251.

引用本文的文献

1
Insights into the Functional Role of ADTRP (Androgen-Dependent TFPI-Regulating Protein) in Health and Disease.深入了解ADTRP(雄激素依赖性TFPI调节蛋白)在健康与疾病中的功能作用。
Int J Mol Sci. 2021 Apr 24;22(9):4451. doi: 10.3390/ijms22094451.
2
Role of ADTRP (Androgen-Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function.ADTRP(雄激素依赖性组织因子途径抑制物调节蛋白)在血管发育和功能中的作用。
J Am Heart Assoc. 2018 Nov 20;7(22):e010690. doi: 10.1161/JAHA.118.010690.
3
Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
基因表达谱分析确定血栓形成和产科抗磷脂综合征中的不同分子特征。
J Autoimmun. 2018 Sep;93:114-123. doi: 10.1016/j.jaut.2018.07.002. Epub 2018 Jul 19.
4
The Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions.小窝蛋白-1作为在真实和模拟微重力条件下培养的甲状腺癌细胞三维生长关键调节因子的重要性
Int J Mol Sci. 2015 Nov 30;16(12):28296-310. doi: 10.3390/ijms161226108.
5
New insights into the biology of tissue factor pathway inhibitor.组织因子途径抑制剂生物学的新见解。
J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S200-7. doi: 10.1111/jth.12897.
6
Biology of tissue factor pathway inhibitor.组织因子途径抑制物的生物学特性。
Blood. 2014 May 8;123(19):2934-43. doi: 10.1182/blood-2013-11-512764. Epub 2014 Mar 11.
7
Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.组织因子途径抑制物剪接变异体的细胞表达和生物学活性。
Curr Opin Hematol. 2013 Sep;20(5):403-9. doi: 10.1097/MOH.0b013e3283634412.
8
Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.比较人组织因子途径抑制物(TFPI)α和 TFPIβ的抑制活性。
J Thromb Haemost. 2013 May;11(5):911-8. doi: 10.1111/jth.12188.
9
Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.小窝优化细胞表面相关组织因子途径抑制剂对组织因子-Factor VIIa 的抑制活性。
Biochem J. 2012 Apr 1;443(1):259-66. doi: 10.1042/BJ20111994.
10
Tissue factor pathway inhibitor: structure-function.组织因子途径抑制剂:结构-功能。
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.